×
0.00578034682080925 0.00578034682080925 0.00578034682080925 0.00578034682080925 0.0115606936416185 0.0173410404624278 0.00705202312138741 -0.0115606936416184
Stockreport

Capricor to Give Update on HOPE-2 Clinical Trial for CAP-1002 at International Conference on Duchenne Muscular Dystrophy

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: GlobeNewswire
Last capricor therapeutics earnings: 11/8 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF LOS ANGELES, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) will provide an update on HOPE-2, its trial for CAP-1002, the company’s lead investigational therapy for the treatment of Duchenne muscular dystrophy, at the 16th International Conference on Duchenne and Becker Muscular Dystrophy taking place in Rome this Friday through Sunday. The three-day conference brings together scientists, physicians, companies, patients and their families to discuss the latest developments in Duchenne and Becker muscular dystrophy. Linda Marbán, Ph.D., Capricor president and chief executive officer, will provide a presentation on Sunday on HOPE-2, a randomized, double-blind, placebo-controlled clinical trial anticipated to begin enrolling participants in March. “Our previous clinical trial, the HOPE-Duchenne Trial, found significant and sustained improvements in skeletal muscle function and cardiac structure following a single dose of intracoronary CAP-1002,” said Dr. Marbán [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS